trending Market Intelligence /marketintelligence/en/news-insights/trending/Jyd_4JmnjT_TvZf4hW0l7w2 content esgSubNav
In This List

BioPharmX adds board member

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


BioPharmX adds board member

BioPharmX Corp.'s board elected Charles Vontz as an independent board member, effective Jan. 17.

Vontz was most recently the president and CEO of Topica Pharmaceuticals.

The company's board now comprises four directors, three of whom are independent.